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Myocardial Infarction in
Patients With PneumoniaWe have read with great interest the report by
Cangemi et al. (1) in a previous issue of the Journal.
The authors reported that myocardial infarction
(MI) is an early complication of pneumonia and
is associated with in vivo platelet activation and
serum thromboxane B2 (TxB2) overproduction. The
researchers found that the baseline serum TxB2
level was signiﬁcantly higher in patients who
develop signs of MI, and that in vivo platelet acti-
vation and overproduction of serum TxB2 formation
were independently associated with MI in a patient
with pneumonia. Also, the authors suggested that
increased TxB2 levels were associated with aspirin
resistance and increased plaque rupture. Although
important ﬁndings, some issues should be considered
in the interpretation of the study results.
The patient with pneumonia may have used
nonsteroidal anti-inﬂammatory drugs (NSAIDs) to
treat pain or fever. Previous studies in rats have
shown that NSAIDs affect the serum TxB2 level.
Akagi et al. (2) reported that NSAIDs (ibuprofen,
loxoprofen sodium, and etodolac) affect the serum
level of TxB2 in rats after oral administration. Also,
all NSAIDs can affect serum TxB2 levels because ofcyclooxygenase inhibition. However, the authors did
not mention the usage of NSAIDs on admission or
in hospital stay. Therefore, increased TxB2 levels
cannot be associated with MI. This issue should
be clariﬁed to correct the interpretation of study
results.
On the other hand, there are some doubts about
the diagnosis of MI. In the study, 24% of all patients
with pneumonia had renal failure. The patients
with renal failure had a high incidence of elevated
troponin levels of about 94%, and this could be
related with decreased glomerular ﬁltration rate. Li
et al. (3) stated that elevation of troponin T in chronic
renal failure was common (63.4%) in the absence of
MI deﬁned by the usual criteria. The researchers
concluded that troponins and electrocardiography
(ECG) were necessary to detect MI. However, the
characteristics of ECG changes were unknown. Stein
et al. (4) reported that in pneumonia patients without
previous cardiopulmonary disease, ECGs show ST-
segment or T-wave changes (21%). Therefore, the
characteristics of ECG changes and the results of
troponin monitoring should be explained before
commenting on the study results.*Goktug Savas, MD
Nihat Kalay, MD
*Erciyes University School of Medicine
Department of Cardiology
38039 Kayseri
Turkey
E-mail: goktug_savas@hotmail.com
http://dx.doi.org/10.1016/j.jacc.2014.12.059REF ER ENCES
1. Cangemi R, Casciaro M, Rossi E, et al., for the SIXTUS Study Group. Platelet
activation is associated with myocardial infarction in patients with pneumonia.
J Am Coll Cardiol 2014;64:1917–25.
2. Akagi Y, Nio Y, Shimada S, et al. Inﬂuence of nonsteroidal anti-inﬂammatory
drugs on the antiplatelet effects of aspirin in rats. Biol Pharm Bull 2011;34:
233–7.
3. Li D, Keffer J, Corry K, et al. Nonspeciﬁc elevation of troponin t levels in
patients with chronic renal failure. Clin Biochem 1995;28:474–7.
4. Stein PD, Matta F, Ekkah M, et al. Electrocardiogram in pneumonia. Am J
Cardiol 2012;15:1836–40.REPLY: Myocardial Infarction inPatients With PneumoniaWe thank Drs. Savas and Kalay for their interest in our
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Epidemiological studies have shown that respira-
tory tract infections are associated with an increased
risk for the development of artery thrombosis as
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1492shown by an increased risk of acute cardiovascular
and cerebrovascular events in the early phase of the
disease (2). We have recently shown a signiﬁcant as-
sociation between platelet activation in vivo and
myocardial infarction (MI), suggesting a role for
platelets as a trigger of myocardial ischemia (1). We
also noted that community-acquired pneumonia
(CAP) patients on treatment with aspirin had not
complete inhibition of platelet thromboxane (Tx) A2,
which could denote an incomplete ability of aspirin to
fully inhibit COX1 (1). Drs. Savas and Kalay raise the
possibility that such incomplete inhibition may
depend on concomitant use of nonsteroidal anti-
inﬂammatory drugs (NSAIDs); however, none of our
CAP patients took NSAIDs during the hospital stay,
and in case of need, paracetamol was used. Another
pharmacological mechanism potentially accounting
for the incomplete inhibition of platelet TxA2 is
related to the aspirin formulation, which was enteric-
coated in 95% of our aspirin-treated patients. Thus, a
previous study demonstrated that enteric-coated
aspirin may be associated with impaired COX1 inhi-
bition, likely because a variable absorption of aspirin
in the gastrointestinal tube (3). The authors also
requested more information on MI diagnosis because
the troponin increase could be related to concomitant
renal disease, and electrocardiographic changes may
not be speciﬁc for MI diagnosis. Although we agree
that renal disease could affect serum troponin levels
of our population (4), an increase of troponin alone,
which was monitored every 12 h from hospitalization,
was insufﬁcient for MI diagnosis; thus, we followed
the universal MI deﬁnition, which requires the coex-
istence of a troponin increase with characteristic ST-
segment changes.*Francesco Violi, MD
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Please note: The members of the The SIXTUS (thromboSIs-related eXTra-
pulmonary oUtcomeS in pneumonia) Study Group are: Fabiana Albanese, MD,
Giuliano Bertazzoni, MD, Elisa Biliotti, MD, Tommaso Bucci, MD, Cinzia Myriam
Calabrese, MD, Roberto Carnevale, PHD, Elisa Catasca, MD, Marco Casciaro, MD,
Andrea Celestini, MD, Rozenn Esvan, MD, Lucia Fazi, MD, Alessio Farcomeni,PhD, Stefania Grieco, MD, Paolo Marinelli, MD, Michela Mordenti, MD, Laura
Napoleone, MD, Paolo Palange, MD, Michela Palumbo, MD, Daniele Pastori, MD,
Ludovica Perri, MD, Pasquale Pignatelli, MD, Marco Proietti, MD, Marco Rivano
Capparuccia, MD, Elisabetta Rossi, MD, Alessandro Russo, MD, Roberta Russo,
MD, Valentino Sarallo, MD, Gabriele Salvatori, MD, Maria Gabriella Scarpellini,
MD, and Ines Ullo, MD.
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Platelet Activation and
PneumoniaIs Soluble P-Selectin the Right Marker?We read with interest the paper by Cangemi et al. (1)
reporting a signiﬁcant association between platelet
activation and myocardial infarction (MI) that was
based on the observation of higher levels of plasma
soluble (s)CD-40L and sp-selectin and serum throm-
boxane (Tx) B2 in patients who were hospitalized for
pneumonia and who had development of MI. About
20 years ago, there was tremendous interest in the
potential utility of p-selectin as a diagnostic marker of
early acute coronary syndromes and as a target for
pharmacological inhibition. However, at the present
time, the utility of sp-selectin as a reliable marker of
platelet activation to identify MI is still a matter of
debate. About 17 years ago, we reported the relation
of sp-selectin with acute MI (AMI) (2). In our pilot
study, sp-selectin levels were determined in identical
samples by 2 different enzyme-linked immunosor-
bent assays at pre-speciﬁed time points in 23 patients
with AMI enrolled in the GUSTO-III (Global Utilization
of Streptokinase and Tissue Plasminogen Activator
for Occluded Coronary Arteries) trial and were
compared with healthy control subjects. Plasma
concentrations of sp-selectin were consistently at
least twice higher in patients with AMI when
measured by use of both assays. We also showed that
sp-selectin rose early after reperfusion, a factor that
may have inﬂuenced the detection of elevated
sp-selectin in the Cangemi study, because only
2 sp-selectin measurements were made in the
latter study. To evaluate the diagnostic utility of
